A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma

发表于 2026-8-15 23:19:05

期刊：Cancers

文献作者：Fangyong Lei; Wenjing Deng; Ying Zhou; Lilan Fang; Xiuxin Lin; Lingyu Qin; Chunming Li; Jian Rao; Gengsheng Yu

出版日期：--

DOI号：10.3390/cancers18010088

下载链接：https://www.mdpi.com/2072-6694/18/1/88/pdf

文献链接：https://doi.org/10.3390/cancers18010088

当前文献来源于 MDPI AG。

备注信息：

发表于 2026-8-15 23:19:06

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[MDPI] A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[MDPI] A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma 一键复制